Genetic counseling for congenital heart disease: New approaches for a new decade

Current Cardiology Reports

Volumn 4, Issue 1, 2002, Pages 68-75

  Hoess, Katy ^a   Goldmuntz, Elizabeth ^a   Pyeritz, Reed E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL HEART MALFORMATION; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HUMAN; PATHOLOGY; REVIEW; RISK FACTOR;

GENETIC COUNSELING; GENETIC SCREENING; HEART DEFECTS, CONGENITAL; HUMAN; RISK FACTORS;

EID: 0036134546     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-002-0129-y     Document Type: Article

References (50)

1. Nora JJ: Multifactorial inheritance hypothesis for the etiology of congenital heart disease. Circulation 1968, 38:604-617.
2. Nora JJ, Nora AH: The evolution of specific genetic and environmental counseling in congenital heart diseases. Circulation 1978, 57:205-213.
3. Rose V, Gold RJM, Lindsay G, et al.: A possible increase in the incidence of congenital heart defects among the offspring of affected parents. J Am Coll Cardiol 1985, 6:376-382.
4. Whittemore R, Wells J, Castellsague X: A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol 1994, 23:1459-1467.
5. Burn J, Brennan P, Holloway S, et al.: Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998, 351:311-316.
6. Clark EB: Mechanisms in the pathogenesis of congenital cardiac malformations. In The Genetics of Cardiovascular Disease. Edited by Pierpont MEM, Moller JH. Boston: Martinus Nijhoff; 1987:3-11.
7. Boughman JA, Neill CA, Ferencz C, et al.: Genetics of congenital heart disease. In Epidemiology of Congenital Heart Disease: The Baltimore-Washington Infant Study, 1981-1989. Edited by Ferencz C, Rubin JD, Loffredo CA, et al. Mount Kisco, NY: Futura; 1993:123-167.
8. Brenner JI, Berg KA, Schneider DS, et al.: Cardiac malformation in relatives of infants with hypoplastic left-heart syndrome. Am J Dis Child 1989, 143:1492-1494.
9. Pyeritz RE, Murphy EA: Genetics and congenital heart disease: perspectives and prospects. J Am Coll Cardiol 1989, 13:1458-1468.
10. Murphy EA, Pyeritz RE: Assessment of genetic risk in congenital heart disease. J Am Coll Cardiol 1991, 18:338-340.
11. International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
12. Venter JC, Adams MD, Myers EW, et al.: The sequence of the human genome. Science 2001, 291:1304-1351.
13. Burn J, Goodship J: Congenital heart disease. In Principles and Practice of Medical Genetics, edn 4. Edited by Rimoin DL, Conner JM, Pyeritz RE, Korf B. Edinburgh: Churchill Livingstone; 2002:1239-1326.
14. Maron BJ, Moller JH, Seidman CE, et al.: Impact of laboratory diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long QT syndrome, and Marfan syndrome. Circulation 1998, 98:1460-1471.
15. GeneTests-GeneClinics: Medical Genetics Information Resource [database online]. Copyright, University of Washington and Children's Health System, Seattle, WA: 1993-2001. Updated weekly. http://www.geneclinics.org or http://www.genetests.org. Accessed October 31, 2001.
16. Schott J-J, Benson DW, Basson CT, et al.: Congenital heart disease caused by mutations in the transcription factor Nkx2.5. Science 1998, 281:108-111.
17. Newbury-Ecob R, Leanage R, Raeburn JA, et al.: The Holt- Oram syndrome: a clinical genetic study. J Med Genet 1996, 33:300-307.
18. Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al.: Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac development pathways. J Clin Invest 1999, 104:1567-1573.
19. Basson CT, Bachinsky DR, Lin RC, et al.: Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997, 15:30-35.
20. Li QL, Newbury-Ecob RA, Terrett JA, et al.: Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 1997, 15:21-29.
21. Basson CT, Huang T, Lin RC, et al.: Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A 1999, 96:919-924.
22. Cross SJ, Ching YH, Li QY, et al.: The mutation spectrum in Holt-Oram syndrome. J Med Genet 2000, 37:785-787.
23. Ruiz-Perez VL, Ide S, Strom TM, et al.: Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet 2000, 24:283-286.
24. Wilson DI, Cross IE, Wren C, et al.: Minimum prevalence of chromosome 22q11 deletions. Am J Hum Genet 1994, 51:A169.
25. McDonald-McGinn DM, Kirshner R, Goldmuntz E, et al.: The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 1999, 10:11-24.
26. Ryan AK, Goodship JA, Wilson DI, et al.: Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997, 34:798-804.
27. Goldmuntz E, Clark BJ, Mitchell LE, et al.: Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998, 32:492-498.
28. McElhinney DB, Clark BJ, Weinberg PM, et al.: Association of chromosome 22q11 deletion with isolated anomalies of aortic arch laterality and branching. J Am Coll Cardiol 2001, 37:2114-2119.
29. Driscoll DA, Salvin J, Sellinger B, et al.: Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 30:813-817.
30. Alagille D, Estrada A, Hadchouel M, et al.: Syndromic paucity of interlobar bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr 1987, 110:195-200.
31. Krantz ID, Smith R, Colliton RP: Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet 1999, 84:56-60.
32. Li L, Krantz ID, Deng Y, et al.: Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997, 16:243-251.
33. Oda T, Elkahloun AG, Pike BL, et al.: Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997, 16:235-242.
34. Eldadah ZA, Hamosh A, Biery NJ, et al.: Familial tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Molec Genet 2001, 10:163-169.
35. Morelli SH, Young L, Reid B, et al.: Clinical analysis of families with heart, midline, and laterality defects. Am J Med Genet 2001, 101:388-392.
36. Gebbia M, Ferrero GB, Pilia G, et al.: X-linked situs abnormalities result from mutations in ZIC3. Nat Genet 1997, 17:305-308.
37. Bamford RN, Roessler E, Burdine RD, et al.: Loss of function mutations in the ECF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000, 26:356-359.
38. Kosaki R, Gebbia M, Kosaki K, et al.: Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet 1999, 82:70-76.
39. Burdine RD, Schier AF: Conserved and divergent mechanisms in left-right axis formation. Genes Dev 2000, 14:763-776.
40. Dietz HC, Pyeritz RE: Marfan syndrome and related disorders. In The Metabolic and Molecular Bases of Inherited Disease, edn 8. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 2001:5287-5312.
41. Pyeritz RE: Marfan syndrome and other disorders of fibrillin. In Principles and Practice of Medical Genetics, edn 4. Edited by Rimoin DL, Conner JM, Pyeritz RE, Korf B. Edinburgh: Churchill Livingstone; 2002:3977-4020.
42. Gott VL, Greene PS, Alejo DE, et al.: Surgery for ascending aortic disease in Marfan patients: a multi-center study. N Engl J Med 1999, 340:1307-1313.
43. DePaepe A, Deitz HC, Devereux RB, et al.: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996, 62:417-426.
44. Yuan B, Thomas JP, von Kodolitsch Y, Pyeritz RE: Comparison of heteroduplex analysis, direct sequencing and enzyme mismatch cleavage for detecting mutations in a large gene, FBN1. Hum Mutation 1999, 14:440-446.
45. Metcalfe K, Rucka AK, Smoot L, et al.: Elastin: mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet 2000, 8:955-963.
46. Johnson LW, Fishman RA, Schneider B, et al.: Familial supravalvular aortic stenosis: report of a large family and review of the literature. Chest 1976, 70:494-500.
47. Ensing GJ, Schmidt MA, Hagler DJ, et al.: Spectrum of findings in a family with nonsyndromic autosomal dominant supravalvular aortic stenosis: a Doppler echocardiographic study. J Am Coll Cardiol 1989, 13:413-419.
48. Wessel A, Pankau R, Kececioglu D, et al.: Three decades of follow- up of aortic and pulmonary vascular lesions in the Williams- Beuren syndrome. Am J Med Genet 1994, 52:297-301.
49. Borg I, Delhanty JDA, Baraitser M: Detection of hemizygosity at the elastin locus by FISH analysis as a diagnostic test in both classical and atypical cases of Williams syndrome. J Med Genet 1995, 32:692-696.
50. Rossiter JP, Morales AJ, Repke JT, et al.: A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995, 173:1599-606.